Benitec Biopharma Limited Sponsored ADR
(NASDAQ : BNTC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.45%201.721.2%$403.92m
GILDGilead Sciences, Inc.
-0.37%72.510.9%$393.01m
CELGCelgene Corporation
0.28%87.441.2%$340.07m
BIIBBiogen Inc.
0.17%334.981.2%$274.44m
ILMNIllumina, Inc.
1.25%351.553.5%$255.39m
REGNRegeneron Pharmaceuticals, Inc.
-1.46%380.842.6%$207.17m
EXASExact Sciences Corporation
-0.87%72.6925.3%$196.95m
VRTXVertex Pharmaceuticals Incorporated
0.33%176.381.9%$160.40m
SRPTSarepta Therapeutics, Inc.
-0.19%152.0616.4%$124.63m
AAgilent Technologies, Inc.
-0.81%68.521.5%$120.51m
ALXNAlexion Pharmaceuticals, Inc.
1.18%119.202.0%$108.76m
ALNYAlnylam Pharmaceuticals, Inc
0.42%93.749.7%$96.21m
NKTRNektar Therapeutics
0.14%58.395.6%$96.10m
BMRNBioMarin Pharmaceutical Inc.
0.61%98.754.4%$91.24m
INCYIncyte Corporation
0.61%67.432.5%$88.24m

Company Profile

Benitec Biopharma Ltd. engages in the development of therapeutics based on patented gene silencing technology called ddRNAi. It develops treatments for chronic and life threatening human conditions, such as oculopharyngeal muscular dystrophy, oncology, wet age-related macular degeneration, and hepatitis B. It operates through the Australia and USA geographical segments. The company was founded by Kenneth C. Reed in 1997 and is headquartered in North Sydney, Australia.